AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Prem Subramanian, MD, PhD, discusses the sustained efficacy of teprotumumab in patients with thyroid eye disease.
CU Anschutz
Rocky Mountain Lions Eye Institute
1675 North Aurora Court
F731
Aurora, CO 80045